Related references
Note: Only part of the references are listed.Plasmodium vivax Sub-Patent Infections after Radical Treatment Are Common in Peruvian Patients: Results of a 1-Year Prospective Cohort Study
Peter Van den Eede et al.
PLOS ONE (2011)
Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
Patrick Georges Cech et al.
PLOS ONE (2011)
Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development
Tais Nobrega de Sousa et al.
PLOS ONE (2011)
Current status of Plasmodium vivax vaccine
Myriam Arevalo-Herrera et al.
HUMAN VACCINES (2010)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory Antibodies
Patchanee Chootong et al.
INFECTION AND IMMUNITY (2010)
Advances and challenges in malaria vaccine development
Peter D. Crompton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria
Paola Martinez et al.
MICROBES AND INFECTION (2010)
A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice
Fernanda Gentil et al.
VACCINE (2010)
DnaSP v5: a software for comprehensive analysis of DNA polymorphism data
P. Librado et al.
BIOINFORMATICS (2009)
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Ric N. Price et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
A multifunctional serine protease primes the malaria parasite for red blood cell invasion
Konstantinos Koussis et al.
EMBO JOURNAL (2009)
Plasmodium falciparum: Genetic and immunogenic characterisation of the rhoptry neck protein PfRON4
Belinda J. Morahan et al.
EXPERIMENTAL PARASITOLOGY (2009)
Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
Simulation of the cost-effectiveness of malaria vaccines
Fabrizio Tediosi et al.
MALARIA JOURNAL (2009)
Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum
Alyssa E. Barry et al.
PLOS ONE (2009)
Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
Shannon L. Takala et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Salim Abdulla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response
Lilian Lacerda Bueno et al.
VACCINE (2008)
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
Emiliana Tjitra et al.
PLOS MEDICINE (2008)
Severe vivax malaria: Newly recognised or rediscovered?
Stephen J. Rogerson et al.
PLOS MEDICINE (2008)
Sequence diversity and natural selection at domain I of the apical membrane antigen I among Indian Plasmodium falciparum populations
Sheena Garg et al.
MALARIA JOURNAL (2007)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure
Mattias Jakobsson et al.
BIOINFORMATICS (2007)
Plasmodium vivax thrombospondin related adhesion protein:: immunogenicity and protective efficacy in rodents and Aotus monkeys
Angelica Castellanos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2007)
Molecular epidemiology of Plasmodium vivax in the state of Amazonas, Brazil
Patricia D. Santos-Ciminera et al.
ACTA TROPICA (2007)
Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran
S Zakeri et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka
T Wickramarachchi et al.
INFECTION AND IMMUNITY (2006)
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community -: art. no. 27
O Branch et al.
MALARIA JOURNAL (2005)
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1 -: art. no. 20
M Imwong et al.
MALARIA JOURNAL (2005)
Efficacy of chloroquine, amodiaquine, sulphadoxine- pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria
F Abacassamo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Assessing the effect of natural selection in malaria parasites
AA Escalante et al.
TRENDS IN PARASITOLOGY (2004)
Migration through host cells:: the first steps of Plasmodium sporozoites in the mammalian host
MM Mota et al.
CELLULAR MICROBIOLOGY (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides
AY Sierra et al.
VACCINE (2003)
Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
AM Espinosa et al.
VACCINE (2003)
Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1
A Cortes et al.
INFECTION AND IMMUNITY (2003)
Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity
R Tewari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Plasmodium vivax promiscuous T-Helper epitopes defined and evaluated as linear peptide chimera immunogens
I Caro-Aguilar et al.
INFECTION AND IMMUNITY (2002)
Plasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes
M Ocampo et al.
PEPTIDES (2002)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates
JM González et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2001)
Diversity in the thrombospondin-related adhesive protein gene (TRAP) of Plasmodium vivax
C Putaporntip et al.
GENE (2001)
The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea
XL Jia et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Share Paper
